Table 3 Number and distribution of observed lymphatic compartments by UML and PTD classifications for each mapping procedure
a. Blue dye mapping | ||||||||
Tumor location | All site | U | UM·MU | M | L | P | T | D |
No. of patients | 323 | 36 | 7 | 171 | 109 | 40 | 141 | 142 |
Distribution of basins | ||||||||
l-GA | 81.4% | 97.2% | 85.7% | 88.9% | 64.2% | 95.0% | 90.8% | 68.3% |
r-GA | 28.2% | 0.0% | 0.0% | 17.5% | 56.0% | 0.0% | 0.0% | 64.1% |
r-GEA | 64.4% | 0.0% | 28.6% | 64.9% | 87.2% | 0.0% | 68.1% | 78.9% |
l-GEA | 5.9% | 19.4% | 42.9% | 5.3% | 0.0% | 30.0% | 5.0% | 0.0% |
p-GA | 1.5% | 13.9% | 0.0% | 0.0% | 0.0% | 12.5% | 0.0% | 0.0% |
#2 | 2.5% | 22.2% | 0.0% | 0.0% | 0.0% | 20.0% | 0.0% | 0.0% |
Number of basins | ||||||||
1 | 34.1% | 58.3% | 57.1% | 33.9% | 24.8% | 52.5% | 40.4% | 22.5% |
2 | 48.3% | 30.6% | 28.6% | 54.4% | 45.9% | 37.5% | 55.3% | 44.4% |
3 | 17.6% | 11.1% | 14.3% | 11.7% | 29.4% | 10.0% | 4.3% | 33.1% |
b. ICG fluorescence mapping | ||||||||
Tumor location | All site | U | UM·MU | M | L | P | T | D |
No. of patients | 93 | 18 | 6 | 44 | 25 | 17 | 35 | 41 |
Distribution of basins | ||||||||
l-GA | 89.2% | 100.0% | 100.0% | 93.2% | 72.0% | 100.0% | 91.4% | 82.9% |
r-GA | 26.9% | 0.0% | 0.0% | 18.2% | 68.0% | 0.0% | 0.0% | 61.0% |
r-GEA | 58.1% | 0.0% | 66.7% | 70.5% | 76.0% | 11.8% | 71.4% | 65.9% |
l-GEA | 4.3% | 5.6% | 50.0% | 0.0% | 0.0% | 17.6% | 2.9% | 0.0% |
p-GA | 1.1% | 5.6% | 0.0% | 0.0% | 0.0% | 5.9% | 0.0% | 0.0% |
#2 | 5.4% | 27.8% | 0.0% | 0.0% | 0.0% | 29.4% | 0.0% | 0.0% |
Number of basins | ||||||||
1 | 33.3% | 66.7% | 33.3% | 27.3% | 20.0% | 52.9% | 37.1% | 22.0% |
2 | 48.4% | 27.8% | 16.7% | 63.6% | 44.0% | 29.4% | 60.0% | 46.3% |
3 | 18.3% | 5.6% | 50.0% | 9.1% | 36.0% | 17.6% | 2.9% | 31.7% |